首页> Cancers> Metabolic Reprogramming in Metastatic Melanoma with Acquired Resistance to Targeted Therapies: Integrative Metabolomic and Proteomic Analysis.

Metabolic Reprogramming in Metastatic Melanoma with Acquired Resistance to Targeted Therapies: Integrative Metabolomic and Proteomic Analysis.

导出 OA

翻译打印收藏纠错

第一作者： Laura,Soumoy

第一单位： Laboratory of Human Anatomy & Experimental Oncology, Faculty of Medicine and Pharmacy, University of Mons, 7000 Mons, Belgium.

作者： Laura,Soumoy ^[1] ; Corentin,Schepkens ^[2] ; Mohammad,Krayem ^[3] ; Ahmad,Najem ^[3] ; Vanessa,Tagliatti ^[2] ; Ghanem E,Ghanem ^[3] ; Sven,Saussez ^[1] ; Jean-Marie,Colet ^[2] ; Fabrice,Journe ^[4]

作者单位： Laboratory of Human Anatomy & Experimental Oncology, Faculty of Medicine and Pharmacy, University of Mons, 7000 Mons, Belgium. ^[1] Laboratory of Human Biology & Toxicology, Faculty of Medicine and Pharmacy, University of Mons, 7000 Mons, Belgium. ^[2] Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet (ULB), 1000 Brussels, Belgium. ^[3] Laboratory of Human Anatomy & Experimental Oncology, Faculty of Medicine and Pharmacy, University of Mons, 7000 Mons, Belgium.;Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet (ULB), 1000 Brussels, Belgium. ^[4]

关键词 cancer metabolic reprogramming metabolic switch metabonomics metastatic melanoma proteomics resistance to drugs targeted therapies

DOI 10.3390/cancers12051323

PMID 32455924

发布时间 2026-03-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交